PRCN-323

N/A

Report date: 2023/10/26 16:01:52

Base Information

Drug NamePRCN-323

Drug Alias NameABCD1 gene therapy - NeuralgenePRCN-323

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionGene transferenceABCD1 gene stimulants

TargetsATP Binding Cassette Subfamily D Member 1

Therapy Area/IndicationsAdrenoleukodystrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesNeuralgene

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNeuralgene

Active IndicationsN/A

Inactive IndicationsAdrenoleukodystrophy

ATC CodeN/A